Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
22,978.00
(
0.12%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
103.82
(
3.13%
)
Bitcoin
67,796.00
(
-1.44%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 130376

Sunday, 11/06/2011 12:07:25 PM

Sunday, November 06, 2011 12:07:25 PM

Post# of 257295

VRTX commits to test 12w Incivek+VX-222+ifn+ribavirin in phase-3




What's the earliest date this could be brought to market? Do you think this is efficient use of shareholder funds? VRTX also has two arms without interferon yet I doubt ribavirin alone will provide the resistance profile needed to prevent breakthrough.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today